Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1
Subscribe to read and download this work.
ABSTRACT
The primary objective of this study was to estimate etravirine activities in a cohort of patients infected with non-B subtype HIV-1 and failing nevirapine based therapy.
Reviews
No reviews yet.
APA
(2026). Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1. Afribary. Retrieved June 14, 2026, from http://library.afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1
MLA
"Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1." Afribary, 6 Jun. 2026, http://library.afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1. Accessed June 14, 2026.
Chicago
"Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1." Afribary (2026). Accessed June 14, 2026. http://library.afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1